Description
Ambroxol-TEVA Oral Solution (Ambroxol Hydrochloride) 7.5 mg/ml. 100 ml
Ingredients:
Each 5 ml contains Ambroxol Hydrochloride 37.5 mg as the active ingredient.
Mechanism of Action:
Ambroxol, a mucolytic agent, acts by breaking down thick mucus in the respiratory tract, facilitating easier expectoration.
Pharmacological Properties:
Ambroxol-TEVA Oral Solution exhibits mucolytic and expectorant properties, aiding in mucus clearance and improving respiratory function.
Indications for Use:
Ambroxol-TEVA Oral Solution is indicated for the treatment of respiratory conditions characterized by the presence of viscid mucus, such as bronchitis and asthma.
Contraindications:
Ambroxol-TEVA Oral Solution should not be administered to individuals with a known hypersensitivity to Ambroxol or any other component of the product.
Side Effects:
Common side effects may include gastrointestinal disturbances, such as nausea and vomiting, as well as allergic reactions like rash or itching.
Usage Instructions:
Prior to administration, ensure thorough shaking of the solution. Utilize the provided measuring cup for precise dosage. The recommended dose for adults and children over 12 years is 10 ml (75 mg) three times daily.
Benefits Compared to Analogues:
Ambroxol-TEVA Oral Solution offers a well-established efficacy in improving mucus clearance and reducing cough frequency, particularly in patients with chronic respiratory conditions.
Suitable Patient Groups:
The formulation is suitable for both adult and pediatric populations, providing a convenient dosing option for individuals of all ages.
Storage and Shelf Life:
Store Ambroxol-TEVA Oral Solution in a cool, dry place away from direct sunlight. Ensure proper sealing of the container. Check the expiration date and do not use the product beyond the stated shelf life.
Packaging Description:
The product is available in a 100 ml bottle of Ambroxol-TEVA Oral Solution, providing a sufficient quantity for multiple doses.
Scientific Evidence:
Ambroxol has been extensively studied for its efficacy in treating respiratory conditions. Clinical trials have demonstrated its effectiveness in improving lung function and reducing exacerbations in patients with COPD.
